PerformanceRiskValuationProfitabilityCashflowLiquidityESGRevenue & Geographic ExposureForecastFinancial GrowthIncome GrowthCashflow GrowthBalance Sheet Growth
1.52 - 1.58
1.19 - 3.37
354.5K / 984.1K (Avg.)
-1.64 | -0.94
Steady, sustainable growth is a hallmark of high-quality businesses. Value investors watch these metrics to confirm that the company's fundamental performance aligns with—or outpaces—its current market valuation.
31.20%
Revenue growth under 50% of ENPH's 63.77%. Michael Burry would suspect a deteriorating sales pipeline or weaker brand.
-78.20%
Negative gross profit growth while ENPH is at 81.53%. Joel Greenblatt would examine cost competitiveness or demand decline.
-1010.38%
Both companies show negative EBIT growth. Martin Whitman would consider macro or sector-specific headwinds.
-7584.19%
Both companies face negative operating income growth. Martin Whitman would suspect broader market or cost hurdles.
-6871.81%
Both companies face declining net income. Martin Whitman would suspect external pressures or flawed business models in the space.
-6763.64%
Negative EPS growth while ENPH is at 9.13%. Joel Greenblatt would expect urgent managerial action on costs or revenue drivers.
-6763.64%
Negative diluted EPS growth while ENPH is at 9.13%. Joel Greenblatt would require immediate efforts to restrain share issuance or boost net income.
1.25%
Share reduction more than 1.5x ENPH's 21.93%. David Dodd would see if the company is taking advantage of undervaluation to retire shares.
1.25%
Diluted share reduction more than 1.5x ENPH's 21.93%. David Dodd would validate if the company is aggressively retiring shares or limiting option exercises.
No Data
No Data available this quarter, please select a different quarter.
39.38%
OCF growth above 1.5x ENPH's 20.13%. David Dodd would confirm a clear edge in underlying cash generation.
41.08%
Positive FCF growth while ENPH is negative. John Neff would see a strong competitive edge in net cash generation.
551.36%
10Y revenue/share CAGR above 1.5x ENPH's 299.43%. David Dodd would confirm if management’s strategic vision consistently outperforms the competitor.
610.09%
5Y revenue/share CAGR above 1.5x ENPH's 299.43%. David Dodd would look for consistent product or market expansions fueling outperformance.
25.83%
3Y revenue/share CAGR under 50% of ENPH's 299.43%. Michael Burry might see a serious short-term decline in relevance vs. the competitor.
-200.41%
Both show negative 10Y OCF/share CAGR. Martin Whitman would question if the entire market or product set is shrinking or too capital-intensive.
-1610.30%
Both show negative mid-term OCF/share growth. Martin Whitman might suspect a challenged environment or large capital demands for both.
-387.08%
Both face negative short-term OCF/share growth. Martin Whitman would suspect macro or cyclical issues hitting them both.
-320.95%
Both face negative decade-long net income/share CAGR. Martin Whitman would suspect a shrinking or highly disrupted sector.
-1901.08%
Both exhibit negative net income/share growth over five years. Martin Whitman would suspect a challenging environment for the entire niche.
-485.94%
Both companies show negative 3Y net income/share growth. Martin Whitman suspects macro or sector-specific headwinds in the short run.
No Data
No Data available this quarter, please select a different quarter.
110.96%
Equity/share CAGR of 110.96% while ENPH is zero. Bruce Berkowitz might see a minor advantage that could compound if the firm maintains positive net worth growth.
25.32%
Equity/share CAGR of 25.32% while ENPH is zero. Bruce Berkowitz sees if minor gains can snowball into a bigger lead soon.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
58.28%
AR growth well above ENPH's 99.41%. Michael Burry fears inflated revenue or higher default risk in the near future.
-15.35%
Inventory is declining while ENPH stands at 6.38%. Joel Greenblatt sees potential cost and margin benefits if sales hold up.
-3.92%
Negative asset growth while ENPH invests at 32.43%. Joel Greenblatt checks if the competitor might capture more market share unless our returns remain higher.
-9.42%
Both erode book value/share. Martin Whitman suspects a difficult environment or poor capital deployment for both players.
-4.16%
We’re deleveraging while ENPH stands at 169.79%. Joel Greenblatt considers if we gain a balance-sheet advantage for potential downturns.
11.79%
R&D growth drastically higher vs. ENPH's 14.93%. Michael Burry fears near-term margin erosion unless breakthroughs are imminent.
33.38%
SG&A growth well above ENPH's 30.26%. Michael Burry sees potential margin erosion unless it translates into higher sales or brand equity.